Report

Global Allergic Conjunctivitis Market Size study, By Drug Class, By Disease Type (Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis ), By Distribution Channel, and Regional Forecasts 2022-2028

  • Publish Date: Oct,2022
  • Report ID: QI037
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Allergic Conjunctivitis Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Allergic Conjunctivitis Market, by Drug Class, 2020-2028 (USD Million)
1.2.3. Global Allergic Conjunctivitis Market, by Disease Type, 2020-2028 (USD Million)
1.2.4. Global Allergic Conjunctivitis Market, by Distribution Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Allergic Conjunctivitis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Allergic Conjunctivitis Market Dynamics
3.1. Allergic Conjunctivitis Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising incidences of allergic conjunctivitis worldwide
3.1.1.2. Increasing prevalence of allergens.
3.1.1.3. Recent approvals from regulating authorities.
3.1.2. Market Challenges
3.1.2.1. Lack of awareness towards allergic conjunctivitis treatment.
3.1.3. Market Opportunities
3.1.3.1. Growing advancements in ocular allergy therapeutics
3.1.3.2. Rising expansion of healthcare services in emerging markets.
Chapter 4. Global Allergic Conjunctivitis Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Allergic Conjunctivitis Market, by Drug Class
6.1. Market Snapshot
6.2. Global Allergic Conjunctivitis Market by Drug Class, Performance - Potential Analysis
6.3. Global Allergic Conjunctivitis Market Estimates & Forecasts by Drug Class 2018-2028 (USD Million)
6.4. Allergic Conjunctivitis Market, Sub Segment Analysis
6.4.1. Antihistamines & Mast Cell Stabilizers
6.4.2. Corticosteroids
Chapter 7. Global Allergic Conjunctivitis Market, by Disease Type
7.1. Market Snapshot
7.2. Global Allergic Conjunctivitis Market by Disease Type, Performance - Potential Analysis
7.3. Global Allergic Conjunctivitis Market Estimates & Forecasts by Disease Type 2018-2028 (USD Million)
7.4. Allergic Conjunctivitis Market, Sub Segment Analysis
7.4.1. Seasonal Allergic Conjunctivitis (SAC)
7.4.2. Perennial Allergic Conjunctivitis (PAC)
Chapter 8. Global Allergic Conjunctivitis Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Allergic Conjunctivitis Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Allergic Conjunctivitis Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
8.4. Allergic Conjunctivitis Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Drug stores & Retail Pharmacies
8.4.3. Online providers
Chapter 9. Global Allergic Conjunctivitis Market, Regional Analysis
9.1. Allergic Conjunctivitis Market, Regional Market Snapshot
9.2. North America Allergic Conjunctivitis Market
9.2.1. U.S. Allergic Conjunctivitis Market
9.2.1.1. Drug Class estimates & forecasts, 2018-2028
9.2.1.2. Disease Type estimates & forecasts, 2018-2028
9.2.1.3. Distribution Channel estimates & forecasts, 2018-2028
9.2.2. Canada Allergic Conjunctivitis Market
9.3. Europe Allergic Conjunctivitis Market Snapshot
9.3.1. U.K. Allergic Conjunctivitis Market
9.3.2. Germany Allergic Conjunctivitis Market
9.3.3. France Allergic Conjunctivitis Market
9.3.4. Spain Allergic Conjunctivitis Market
9.3.5. Italy Allergic Conjunctivitis Market
9.3.6. Rest of Europe Allergic Conjunctivitis Market
9.4. Asia-Pacific Allergic Conjunctivitis Market Snapshot
9.4.1. China Allergic Conjunctivitis Market
9.4.2. India Allergic Conjunctivitis Market
9.4.3. Japan Allergic Conjunctivitis Market
9.4.4. Australia Allergic Conjunctivitis Market
9.4.5. South Korea Allergic Conjunctivitis Market
9.4.6. Rest of Asia Pacific Allergic Conjunctivitis Market
9.5. Latin America Allergic Conjunctivitis Market Snapshot
9.5.1. Brazil Allergic Conjunctivitis Market
9.5.2. Mexico Allergic Conjunctivitis Market
9.6. Rest of The World Allergic Conjunctivitis Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AbbVie, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Ajanta Pharma Limited
10.2.3. Akron Operating Company LLC
10.2.4. Alembic Pharmaceuticals Ltd.
10.2.5. Bausch Health Companies Inc.
10.2.6. Cipla Ltd
10.2.7. Grevis Pharmaceutical Private Limited
10.2.8. Indoco Remedies Ltd.
10.2.9. Jabs Biotech Pvt. Ltd.
10.2.10. JAWA Pharmaceuticals Pvt. Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption